Lymphocytic sensitization to insulin as a risk factor of diabetes mellitus

Terapevticheskii Arkhiv

Volumn 81, Issue 11, 2009, Pages 56-59

  Asfandiyarova, N S ^a  

^a Central District Hospital   (Russian Federation)

Author keywords

Cell mediated Immunity; Diabetes; Insulin; Prediabetes; Risk factors

Indexed keywords

INSULIN;

AGING; ARTICLE; AUTOIMMUNITY; BODY MASS; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; HUMAN; IMMUNOLOGY; LYMPHOCYTE; MALE; MIDDLE AGED; RISK FACTOR; SEX DIFFERENCE;

AGING; AUTOIMMUNITY; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; INSULIN; LYMPHOCYTES; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS;

EID: 77950342733     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Wild S., Roillc G., Green A. et al. Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabet. Care 2004; 27: 1047-1053. (Pubitemid 38579764)
2. Roberts B. yy., Cech I. Viral infection can induce the production of autoantibodies. South. Med. J. 2005; 98: 686-692.
3. Sun Y., Pel W., Wu Y., Yang Y. An association of Herpes Simplex virus type 1 infection with type 2 diabetes. Diabet. Care 2005; 28: 435-436. (Pubitemid 40170957)
4. Arfandiyarova N. S., Kolcheva N. G., Ryazonlsev I. V., Ryazantsev V. S. Risk factors for stroke in type 2 diabetes mellitus. Diabet. Vase. Dls. Res. 2006; 3: 57-60.
5. Worid Health Organization: Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization; 1999.
6. Goodwin J. S., Bankhurst A. D., Messner R. P. Suppression of human T-cell mitogenesis by prostaglandin. J. Exp. Med. 1977; 146: 1719-1734.
7. American Diabetes Association: Screening for type 2 diabetes. Diabet. Care 2003; 26: S21-S24.
8. Kanaya A. M., Fyr C. L. de Rekeneire N. et al. Predicting the development of diabetes in older adults. Diabet. Care 2005; 28: 404-408.
9. Pyörälä M., Mieltinen H., Halonen P. et al. Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men. Artherioscl. Thromb. Vas. Biol. 2000; 20: 538-544.
10. Hanley A. J. G., Williams K., Stem M. P. Haffner S. M. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease. Diabet. Care 2002; 25: 1177-1184. (Pubitemid 41071169)
11. Netea M. G., Tack C. J., Netten P M. et al. The effect of salicilates on insulin sensitivity. J. Clin. Invest. 2001; 108: 1723-1724.
12. Hundai R. S., Petersen K. F., Mayerson A. B. Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes. J. Clin. Invest. 2002; 109: 1321-1326. (Pubitemid 34546896)
13. Chait A. Hyperglycemia vs. metabolic syndrome in type 2 diabetes (abstr.). Diabet. Vase. Dis. Res. 2004; 1: 103.
14. Pickup J. C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabet. Care 2004; 27: 813-823. (Pubitemid 38280558)
15. Sioholm A., Nystrom T. Endothelial inflammation in insulin resistance. Lancet 2005; 365 (12): 610-612. (Pubitemid 40247919)